BILL ANALYSIS
S2392
NEUTRALVeterans’ Compensation Cost-of-Living Adjustment Act of 2025
S2392 (Veterans’ Compensation Cost-of-Living Adjustment Act of 2025) carries an AI-assessed market impact score of 4/10 with a neutral outlook for investors. The primary sectors impacted are Healthcare. View the full bill text on Congress.gov.
4/10
Impact Score
neutral
Market Sentiment
0
Affected Stocks
1
Sectors Impacted
Key Takeaways for Investors
Public Law No: 119-42 mandates a cost-of-living adjustment for veterans' disability and dependency compensation, effective December 1, 2025.
The adjustment percentage will match the Social Security cost-of-living increase for the same period.
This law primarily impacts federal outlays for veterans' benefits and does not create direct funding opportunities for private sector entities.
How S2392 Affects the Market
This legislation has a neutral market implication as it primarily concerns adjustments to federal benefit payments rather than new spending or regulatory changes affecting specific industries or companies. While veterans' purchasing power may slightly increase, this is unlikely to translate into a measurable impact on publicly traded companies. No specific tickers are directly affected.
Bill Details
| Metric | Value |
|---|---|
| Bill Number | S2392 |
| Impact Score | 4/10Certainty: Signed into law · Financial Magnitude: No explicit funding identified · Strategic Weight: AI qualitative assessment: 4/10 · Market Penetration: No specific companies; 1 sector(s) identified |
| Market Sentiment | neutral |
| Event Date | |
| Affected Sectors | Healthcare |
| Affected Stocks | N/A |
| Source | View on Congress.gov → |
Summary
The Veterans’ Compensation Cost-of-Living Adjustment Act of 2025 (Public Law No: 119-42) was signed into law on November 25, 2025. This act mandates an increase in various veterans' disability and dependency compensation rates, effective December 1, 2025, mirroring the Social Security cost-of-living adjustment. While directly impacting veterans' benefits, it does not specify new funding authorizations or appropriations for private sector entities.